Monitoring the effect of therapy on a patient with a neuroendocrine tumor of the pancreas with PET/CT, 68Ga-DOTATATE - case report

Abstract

Neuroendocrine tumors (NET) are a rare diagnosis, often without symptoms or mimicking other different symptoms. Тhey are a heterogeneous group of tumors derived from neuroendocrine cells, most commonly of the gastrointestinal tract, but may originate also from other organs including the pancreas, lungs, ovaries, thyroid, pituitary, and adrenal glands (3). Due to the difficult diagnosis, NET‘s are detected at a late stage in their development, often already locally advanced or metastasized. PET/CT with 68 Gallium DOTATATE proved to be an effective imaging method not only for the primary diagnosis of NET and subsequent therapeutic behavior, but also for evaluating the effect of the treatment. (1) We present a case of a positive PET/CT scan, performed with Ga-68 DOTATATE in the topical location of the tail of the pancreas after therapy with Sandostain lar.